You are viewing a free limited preview of Alcresta
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Alcresta

Private Company Ticker Symbol™: (ALCRP)

Business Summary

Alcresta is a privately-held, venture capital backed biotherapeutics company. Alcresta is headquartered in Newton, Massachusetts.

Overview & Corporate Organization

Basic Information

Fiscal Year End:12/31
City:Newton
State/Province:Massachusetts
Country:United States
Phone:View
Website:www.alcresta.com

Industry Information

Industry Codes

PICS™:1500107
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Biotherapeutics

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Alcresta displays the venture capital rounds, angel investments, debt or other funding raised by Alcresta.
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Sep. 2011ViewAVenture Capital
Sep. 2011ViewAVenture Capital
Sep. 2011ViewAVenture Capital
DetailsTotal Round A View
Apr. 2012ViewAVenture Capital
Apr. 2012ViewAVenture Capital
Apr. 2012ViewAVenture Capital
Apr. 2012ViewAVenture Capital
DetailsTotal Round A View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on Alcresta, you can see the following:

You are viewing a free limited preview of Alcresta
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access